7-57450324-A-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001159279.1(ZNF716):āc.36A>Cā(p.Glu12Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000644 in 1,613,812 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001159279.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ZNF716 | NM_001159279.1 | c.36A>C | p.Glu12Asp | missense_variant | 1/4 | ENST00000420713.2 | NP_001152751.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ZNF716 | ENST00000420713.2 | c.36A>C | p.Glu12Asp | missense_variant | 1/4 | 4 | NM_001159279.1 | ENSP00000394248 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000336 AC: 51AN: 151950Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.000268 AC: 67AN: 249622Hom.: 0 AF XY: 0.000280 AC XY: 38AN XY: 135498
GnomAD4 exome AF: 0.000676 AC: 988AN: 1461748Hom.: 1 Cov.: 31 AF XY: 0.000663 AC XY: 482AN XY: 727190
GnomAD4 genome AF: 0.000335 AC: 51AN: 152064Hom.: 0 Cov.: 31 AF XY: 0.000296 AC XY: 22AN XY: 74340
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 06, 2021 | The c.36A>C (p.E12D) alteration is located in exon 1 (coding exon 1) of the ZNF716 gene. This alteration results from a A to C substitution at nucleotide position 36, causing the glutamic acid (E) at amino acid position 12 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at